News
-
May 31, 2023
C-Path’s Transplant Therapeutics Consortium’s Work Highlighted in Recent Publication in the American Journal of Transplantation
C-Path’s Transplant Therapeutics Consortium is pleased to announce the recent publication in the American Journal of Transplantation by Klemens Budde and Bruce Kaplan, “Stronger together: lessons from the iBox qualification process.” The article highlights TTC’s work as the only community-based public-private partnership focused on reinvigorating drug development in transplantation. As the manuscript states, “The close collaboration... -
May 25, 2023
C-Path Welcomes Red Nucleus Clinical
C-Path is proud to welcome Red Nucleus Clinical as the newest member of its Electronic Clinical Outcome Assessment (eCOA) Consortium. Comprised of 22 firms that provide electronic data collection technologies and services for capturing patient-reported outcome and other clinical outcome assessment data in clinical trials, eCOA Consortium members collaborate in a pre-competitive environment to support and conduct... -
May 2, 2023
C-Path’s CDRC Meeting Highlights the Importance of Drug Repurposing
The Critical Path Institute’s CURE Drug Repurposing Collaboratory and FDA hosted their annual meeting April 18-20 to bring together stakeholders in drug repurposing. TUCSON, Ariz., May 4, 2023 — The CURE Drug Repurposing Collaboratory (CDRC) held a three-day annual meeting, April 18- 20, in Crystal City, VA. The event, hosted for both live and virtual... -
April 14, 2023
Rare Disease COA Consortium Announces Publication of Open Access Article
C-Path’s Rare Disease COA Consortium is pleased to announce that “Approaches to the Assessment of Clinical Benefit of Treatments for Conditions That Have Heterogeneous Symptoms and Impacts: Potential Applications in Rare Disease” was published online in the April 2023 issue of Value in Health. This publication identifies assessment approaches used in clinical trials to address... -
March 29, 2023
C-Path Appoints Key Scientific Leaders to Executive Roles
TUCSON, Ariz., March 29, 2023 — Critical Path Institute (C-Path) announced today the appointment of three accomplished leaders to key executive roles within the organization. Cheryl D. Coon, Ph.D., joins C-Path as the Vice President for the Clinical Outcome Assessment (COA) Program. Shu Chin Ma, Ph.D., M.Sc., M.Phil., EMBA, has been named Vice President of...